Milgamma N (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride)

Milgamma N is used to correct deficiencies in the vitamin B complex and to support peripheral nerve function.

• Vitamin B1 deficiency: restores thiamine levels and helps normalize carbohydrate metabolism.
• Vitamin B6 deficiency: replenishes pyridoxine, aiding amino‑acid metabolism and neurotransmitter synthesis.
• Vitamin B12 deficiency: supplies cyanocobalamin, essential for red‑cell formation and myelin maintenance.
• Peripheral neuropathy: provides combined B‑vitamins that may improve nerve conduction and reduce symptoms.

• The three B‑vitamins in Milgamma N act as essential co‑enzymes in cellular metabolism. Thiamine (B1) participates in the decarboxylation of pyruvate, facilitating carbohydrate oxidation. Pyridoxine (B6) serves as a co‑factor for transamination reactions and neurotransmitter synthesis. Cyanocobalamin (B12) is required for methylmalonyl‑CoA mutase activity and for the regeneration of methionine, supporting DNA synthesis and myelin formation. Together they enhance metabolic pathways and nerve function.

Adverse reactions may occur after intramuscular administration of Milgamma N.

Common Side Effects

• Pain or tenderness at the injection site.
• Redness or mild swelling around the injection area.
• Low‑grade fever or chills.
• Headache.
• Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects

• Anaphylactic reaction, including rash, wheezing, or hypotension.
• Severe hypotension or shock.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Acute hemolysis in patients with G6PD deficiency.
• Persistent neurological symptoms unrelated to deficiency correction.

Milgamma N should be used with attention to specific clinical considerations.

• Pregnancy: consult a healthcare professional before use.
• Breastfeeding: only use if clearly indicated by a physician.
• Renal impairment: monitor vitamin levels and adjust therapy as needed.
• Known hypersensitivity to any B‑vitamin component: avoid administration.
• Concomitant medications: review for potential interactions before prescribing.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Milgamma N may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid)

• Methotrexate: may increase toxicity due to altered folate metabolism.
• Phenytoin: can reduce pyridoxine effectiveness, worsening deficiency.
• High‑dose vitamin C: may interfere with cyanocobalamin absorption.

Moderate Interactions (Monitor Closely)

• Tetracycline antibiotics: may affect absorption of oral B‑vitamins, though less relevant for injection.
• Oral contraceptives: may alter vitamin B metabolism, requiring periodic monitoring.